Skip to Main Content
Table 2 —

Outcome measures of all 314 (84%) of type 2 diabetic patients with postintervention data

nBaselineMean changeP
HbA1c (%) 
 Experimental 137 7.7 ± 0.2 −0.3 ± 0.1 0.02 
 Control 133 7.9 ± 0.2 −0.2 ± 0.1 0.18 
Systolic blood pressure (mmHg) 
 Experimental 158 143 ± 1.8 −6.3 ± 2.1 0.003 
 Control 155 141 ± 1.8 −1.0 ± 1.9 0.61 
Diastolic blood pressure (mmHg) 
 Experimental 158 77 ± 0.90 −2.4 ± 1.1 0.03 
 Control 154 77 ± 0.96 −1.6 ± 1.2 0.19 
Cholesterol (mmol/l) 
 Experimental 158 5.46 ± 0.10 −0.25 ± 0.08 0.0006 
 Control 157 5.39 ± 0.10 −0.06 ± 0.09 0.45 
nBaselineMean changeP
HbA1c (%) 
 Experimental 137 7.7 ± 0.2 −0.3 ± 0.1 0.02 
 Control 133 7.9 ± 0.2 −0.2 ± 0.1 0.18 
Systolic blood pressure (mmHg) 
 Experimental 158 143 ± 1.8 −6.3 ± 2.1 0.003 
 Control 155 141 ± 1.8 −1.0 ± 1.9 0.61 
Diastolic blood pressure (mmHg) 
 Experimental 158 77 ± 0.90 −2.4 ± 1.1 0.03 
 Control 154 77 ± 0.96 −1.6 ± 1.2 0.19 
Cholesterol (mmol/l) 
 Experimental 158 5.46 ± 0.10 −0.25 ± 0.08 0.0006 
 Control 157 5.39 ± 0.10 −0.06 ± 0.09 0.45 

Data are means ± SEM.

Close Modal

or Create an Account

Close Modal
Close Modal